Eytan Ruppin
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Eytan Ruppin
Jun 25, 2024, 03:11 |
Blog
Eytan Ruppin: Analyzing Tumor Microenvironment using bulk transcriptomics with Machine Learning
Eytan Ruppin, Chief of the Cancer Data Science Lab of the National Institute of Health, shared…
May 20, 2024, 14:56 |
Insight
Eytan Ruppin: We introduce DEPLOY for the diagnosis of CNS tumor subtypes
Eytan Ruppin, Chief of the Cancer Data Science Lab of the National Institute of Health,…
May 13, 2024, 08:24 |
Blog
Monica Bertagnolli: AI Tool Has Promise for Matching Cancer Drugs to Patients
Monica Bertagnolli shared a post on LinkedIn: ''AI Tool Using Single-Cell Data Has Promise for Optimally…
May 1, 2024, 11:01 |
Blog
An AI tool to predict cancer response to drugs - NCI Center for Cancer Research
NCI Center for Cancer Research shared a post on LinkedIn: "IN THE NEWS: In case you…
Jan 15, 2024, 01:31 |
Insight
Eytan Ruppin: The very first systematic review and analysis on synthetic lethality in oncology
Quoting Eytan Ruppin, Chief at the Cancer Data Science Lab of the National Institute of Health…
Sep 24, 2023, 18:21 |
Insight
Eytan Ruppin: We present IRIS: a machine-learning method aimed at identifying candidate ligand-receptor interactions that are likely to mediate immune checkpoint blockade resistance in the tumor microenvironment.
All:
6
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube